GL1X · GenesisL1 explorer

MolNFT v1 · #131692 · protein

Crystal structure of human cathepsin-S with bound ligand

5QC1 · Cathepsin S: “Crystal structure of human cathepsin-S with bound ligand”. X-ray diffraction, 1 ligand (B9S), 4 pockets (best druggability 0.75). MolNFT v1 #131692 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5QC1
Type
protein
Length
442 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cathepsin S
EC
3.4.22.27
UniProt
P25774
Ligands
B9S
Pockets
4 · best druggability 0.75

Structure

x-ray diffraction · 1 distinct chain · 29% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BCathepsin S (EC 3.4.22.27)protein22129% helix, 24% strandP25774

Ligands and binding sites

  • B9S · (2S)-1-(4,4-dimethylpiperidin-1-yl)-3-{3-[3-({[(4-fluorophenyl)methyl]amino}methyl)-4-(trifluoromethyl) phenyl]-5-(methylsulfonyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridin-1-yl}propan-2-ol · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16550.750.8175empty
2770.500.8418empty
31170.430.7725empty
41260.410.7523empty

Interfaces

1 interface between chains.

  • A–B · 604 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide (disulfide).

Compared structures

  • 5QC1 · Crystal structure of human Cathepsin-S with bound ligand · the same entry in another collection · chain A against A, TM-score 1.00
  • P25774 · AlphaFold monomer V2.0 prediction for cathepsin S (P25774) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.